CoMind
Neurosensing platform
- 21-100 employees
- B2B
- Biology
- Machine Learning
- SaaS
- Science
- Farringdon, London, UK
Jump to section
Company mission
To change the way humans interact with machines, and better understand the human brain and neurological disorders.
Our take
Brain-computer interfaces are attracting increasing research and media attention due to their potential to help understand the human brain and harness the technology to treat neurological disorders. However, current strategies involve implanting invasive electrodes into the brain to access neural signals - so CoMind is creating non-invasive brain-computer interface hardware and software to communicate with the human brain.
The company is initially focusing on augmenting the neocortex with AI. This is the area of the brain responsible for brain functions such as sensory perception, cognition, motor commands and language, so its a target for improving human cognition and vision. To achieve this, CoMind is building a new form of neural imaging technology, coupled with advanced machine learning techniques.
If its technology works, CoMind could have a wide range of exciting applications in research and clinical settings. The company's plans for the future include a continuation of the research and development into their technology, realised by both technological developments and the building out of its team.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Share Options
- Extended Parental leave
- Weekly team lunch: Once a week we provide a team lunch, whether it's a spread of food in the office or picnic in a nearby park
- The chance to help grow a company and its culture from the ground up
Funding (last 2 of 3 rounds)
Oct 2025
$60m
SERIES A
Nov 2023
$27m
SERIES A
Total funding: $97m
This company has top investors
Leadership
James Dacombe
(CEO & Founder)Experience as a software engineer at CoDesigned building applications and using machine learning.